These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 25007947
21. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan. Akawaza S, Kawasaki E, Yano M, Abiru N, Yamaguchi Y, Nagataki S. Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640 [Abstract] [Full Text] [Related]
22. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. De Block CE, De Leeuw IH, Van Gaal LF. Diabetes Care; 2005 Jul; 28(7):1649-55. PubMed ID: 15983315 [Abstract] [Full Text] [Related]
24. Orthostatic hypotension in diabetic patients-10-year follow-up study. Gaspar L, Kruzliak P, Komornikova A, Celecova Z, Krahulec B, Balaz D, Sabaka P, Caprnda M, Kucera M, Rodrigo L, Uehara Y, Dukat A. J Diabetes Complications; 2016 Jul; 30(1):67-71. PubMed ID: 26412028 [Abstract] [Full Text] [Related]
25. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Dotta F, Gianani R, Previti M, Lenti L, Dionisi S, D'Erme M, Eisenbarth GS, Di Mario U. Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721 [Abstract] [Full Text] [Related]
26. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. Jaeger C, Hering BJ, Hatziagelaki E, Federlin K, Bretzel RG. J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926 [Abstract] [Full Text] [Related]
30. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender. Zimmet PZ, Elliott RB, Mackay IR, Tuomi T, Rowley MJ, Pilcher CC, Knowles WJ. Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024 [Abstract] [Full Text] [Related]
31. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E. Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463 [Abstract] [Full Text] [Related]
32. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus. Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG. Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966 [Abstract] [Full Text] [Related]
38. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study. Happich M, Breitscheidel L, Meisinger C, Ulbig M, Falkenstein P, Benter U, Watkins J. Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744 [Abstract] [Full Text] [Related]
39. [Vascular complications of diabetes]. Wautrecht JC. Rev Med Brux; 1995 Jun; 16(4):262-5. PubMed ID: 7481239 [Abstract] [Full Text] [Related]